{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:57:24Z","timestamp":1777377444265,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,21]],"date-time":"2013-08-21T00:00:00Z","timestamp":1377043200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00213-013-3239-x","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T09:22:03Z","timestamp":1376990523000},"page":"305-314","source":"Crossref","is-referenced-by-count":11,"title":["Socio-demographic and clinical characteristics of heavy and non-heavy smokers among schizophrenia inpatients in a Chinese Han population"],"prefix":"10.1007","volume":"231","author":[{"given":"Xiang Yang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Long","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei Hong","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu","family":"De Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,21]]},"reference":[{"key":"3239_CR1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1192\/bjp.186.3.215","volume":"186","author":"MC Aguilar","year":"2005","unstructured":"Aguilar MC, Gurpegui M, Diaz FJ, de Leon J (2005) Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. Br J Psychiatry 186:215\u2013221","journal-title":"Br J Psychiatry"},{"issue":"2","key":"3239_CR2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.psychres.2006.05.021","volume":"150","author":"A Baker","year":"2007","unstructured":"Baker A, Richmond R, Haile M, Lewin TJ, Carr VJ, Taylor RL, Constable PM, Jansons S, Wilhelm K, Moeller-Saxone K (2007) Characteristics of smokers with a psychotic disorder and implications for smoking interventions. Psychiatry Res 150(2):141\u2013152","journal-title":"Psychiatry Res"},{"issue":"6\u20137","key":"3239_CR3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/j.1440-1614.2006.01841.x","volume":"40","author":"M Barnes","year":"2006","unstructured":"Barnes M, Lawford BR, Burton SC, Heslop KR, Noble EP, Hausdorf K, Young RM (2006) Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use? Aust N Z J Psychiatr 40(6\u20137):575\u2013580","journal-title":"Aust N Z J Psychiatr"},{"issue":"1\u20133","key":"3239_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2010.02.1030","volume":"119","author":"J Bobes","year":"2010","unstructured":"Bobes J, Arango C, Garcia-Garcia M, Rejas J (2010) Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res 119(1\u20133):101\u2013109","journal-title":"Schizophr Res"},{"key":"3239_CR5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.177.3.212","volume":"177","author":"S Brown","year":"2000","unstructured":"Brown S, Inskip H, Barraclough B (2000) Causes of the excess mortality of schizophrenia. Br J Psychiatry 177:212\u2013217","journal-title":"Br J Psychiatry"},{"issue":"5","key":"3239_CR6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4088\/JCP.v65n0519","volume":"65","author":"SM Curkendall","year":"2004","unstructured":"Curkendall SM, Mo J, Glasser DB, Rose Stang M, Jones JK (2004) Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiatry 65(5):715\u2013720","journal-title":"J Clin Psychiatry"},{"key":"3239_CR7","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1038\/tp.2012.41","volume":"2","author":"SP David","year":"2012","unstructured":"David SP, Hamidovic A, Chen GK, Bergen AW, Wessel J, Kasberger JL, Brown WM, Petruzella S, Thacker EL, Kim Y, Nalls MA, Tranah GJ, Sung YJ, Ambrosone CB, Arnett D, Bandera EV, Becker DM, Becker L, Berndt SI, Bernstein L, Blot WJ, Broeckel U, Buxbaum SG, Caporaso N, Casey G, Chanock SJ, Deming SL, Diver WR, Eaton CB, Evans DS, Evans MK, Fornage M, Franceschini N, Harris TB, Henderson BE, Hernandez DG, Hitsman B, Hu JJ, Hunt SC, Ingles SA, John EM, Kittles R, Kolb S, Kolonel LN, Le Marchand L, Liu Y, Lohman KK, McKnight B, Millikan RC, Murphy A, Neslund-Dudas C, Nyante S, Press M, Psaty BM, Rao DC, Redline S, Rodriguez-Gil JL, Rybicki BA, Signorello LB, Singleton AB, Smoller J, Snively B, Spring B, Stanford JL, Strom SS, Swan GE, Taylor KD, Thun MJ, Wilson AF, Witte JS, Yamamura Y, Yanek LR, Yu K, Zheng W, Ziegler RG, Zonderman AB, Jorgenson E, Haiman CA, Furberg H (2012) Genome-wide meta-analyses of smoking behaviors in African Americans. Transl Psychiatry 2:e119","journal-title":"Transl Psychiatry"},{"issue":"3","key":"3239_CR8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/schbul\/22.3.405","volume":"22","author":"J Leon de","year":"1996","unstructured":"de Leon J (1996) Smoking and vulnerability for schizophrenia. Schizophr Bull 22(3):405\u2013409","journal-title":"Schizophr Bull"},{"issue":"2\u20133","key":"3239_CR9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","volume":"76","author":"J Leon de","year":"2005","unstructured":"de Leon J, Diaz FJ (2005) A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76(2\u20133):135\u2013157","journal-title":"Schizophr Res"},{"issue":"3","key":"3239_CR10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1176\/ajp.152.3.453","volume":"152","author":"J Leon de","year":"1995","unstructured":"de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM (1995) Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry 152(3):453\u2013455","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"3239_CR11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0920-9964(01)00192-X","volume":"56","author":"J Leon de","year":"2002","unstructured":"de Leon J, Tracy J, McCann E, McGrory A, Diaz FJ (2002) Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophr Res 56(1\u20132):55\u201365","journal-title":"Schizophr Res"},{"issue":"5","key":"3239_CR12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.pnpbp.2005.04.031","volume":"29","author":"J Leon de","year":"2005","unstructured":"de Leon J, Diaz FJ, Josiassen RC, Cooper TB, Simpson GM (2005) Does clozapine decrease smoking? Prog Neuropsychopharmacol Biol Psychiatry 29(5):757\u2013762","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1\u20133","key":"3239_CR13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.schres.2008.06.004","volume":"104","author":"FJ Diaz","year":"2008","unstructured":"Diaz FJ, Vel\u00e1squez DM, Susce MT, de Leon J (2008) The association between schizophrenia and smoking: unexplained by either the illness or the prodromal period. Schizophr Res 104(1\u20133):214\u2013219","journal-title":"Schizophr Res"},{"issue":"1","key":"3239_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eurpsy.2008.07.007","volume":"24","author":"A Diehl","year":"2009","unstructured":"Diehl A, Reinhard I, Schmitt A, Mann K, Gattaz WF (2009) Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial. Eur Psychiatry 24(1):33\u201340","journal-title":"Eur Psychiatry"},{"issue":"2","key":"3239_CR15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10550490601184415","volume":"16","author":"L Dixon","year":"2007","unstructured":"Dixon L, Medoff DR, Wohlheiter K, DiClemente C, Goldberg R, Kreyenbuhl J, Adams C, Lucksted A, Davin C (2007) Correlates of severity of smoking among persons with severe mental illness. Am J Addict 16(2):101\u2013110","journal-title":"Am J Addict"},{"key":"3239_CR16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0893-133X(00)00218-9","volume":"24","author":"LB Dunn","year":"2001","unstructured":"Dunn LB, Jeste DV (2001) Enhancing informed consent for research and treatment. Neuropsychopharmacology 24:595\u2013607","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"3239_CR17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1176\/appi.ajp.163.8.1323","volume":"163","author":"LB Dunn","year":"2006","unstructured":"Dunn LB, Nowrangi MA, Palmer BW, Jeste DV, Saks ER (2006) Assessing decisional capacity for clinical research or treatment: a review of instruments. Am J Psychiatry 163(8):1323\u20131334","journal-title":"Am J Psychiatry"},{"issue":"11","key":"3239_CR18","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.157.11.1835","volume":"157","author":"TP George","year":"2000","unstructured":"George TP, Ziedonis DM, Feingold A, Pepper WT, Satterburg CA, Winkel J, Rounsaville BJ, Kosten TR (2000) Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry 157(11):1835\u20131842","journal-title":"Am J Psychiatry"},{"issue":"9","key":"3239_CR19","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/ajp.149.9.1189","volume":"149","author":"DC Goff","year":"1992","unstructured":"Goff DC, Henderson DC, Amico E (1992) Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am J Psychiatry 149(9):1189\u20131194","journal-title":"Am J Psychiatry"},{"issue":"6","key":"3239_CR20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","volume":"150","author":"CH Hennekens","year":"2005","unstructured":"Hennekens CH, Hennekens AR, Hollar D, Casey DE (2005) Schizophrenia and increased risks of cardiovascular disease. Am Heart J 150(6):1115\u20131121","journal-title":"Am Heart J"},{"issue":"12","key":"3239_CR21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/apc.2005.19.813","volume":"19","author":"S Himelhoch","year":"2005","unstructured":"Himelhoch S, Medoff DR (2005) Efficacy of antidepressant medication among HIV-positive individuals with depression: a systematic review and meta-analysis. AIDS Patient Care STDS 19(12):813\u2013822","journal-title":"AIDS Patient Care STDS"},{"issue":"3","key":"3239_CR22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/sj.npp.1300651","volume":"30","author":"B Hitsman","year":"2005","unstructured":"Hitsman B, Spring B, Wolf W, Pingitore R, Crayton JW, Hedeker D (2005) Effects of acute tryptophan depletion on negative symptoms and smoking topography in nicotine-dependent schizophrenics and nonpsychiatric controls. Neuropsychopharmacology 30(3):640\u2013648","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"3239_CR23","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.jpsychires.2011.07.011","volume":"45","author":"YZ Hou","year":"2011","unstructured":"Hou YZ, Xiang YT, Yan F, Ungvari GS, Dickerson F, Chiu HF, Lai KY, Lee EH, Li WY, Li WX, Zhu YL, Dixon LB (2011) Cigarette smoking in community-dwelling patients with schizophrenia in China. J Psychiatr Res 45(12):1551\u20131556","journal-title":"J Psychiatr Res"},{"issue":"2","key":"3239_CR24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/10550490590924728","volume":"14","author":"D Kalman","year":"2005","unstructured":"Kalman D, Morissette SB, George TP (2005) Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 14(2):106\u2013123","journal-title":"Am J Addict"},{"issue":"11","key":"3239_CR25","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1176\/ajp.156.11.1751","volume":"156","author":"C Kelly","year":"1999","unstructured":"Kelly C, McCreadie RG (1999) Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry 156(11):1751\u20131757","journal-title":"Am J Psychiatry"},{"issue":"4","key":"3239_CR26","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/schbul\/sbp152","volume":"37","author":"DL Kelly","year":"2011","unstructured":"Kelly DL, McMahon RP, Wehring HJ, Liu F, Mackowick KM, Boggs DL, Warren KR, Feldman S, Shim JC, Love RC, Dixon L (2011) Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull 37(4):832\u2013838","journal-title":"Schizophr Bull"},{"issue":"3","key":"3239_CR27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/schbul\/sbq124","volume":"38","author":"DL Kelly","year":"2012","unstructured":"Kelly DL, Raley HG, Lo S, Wright K, Liu F, McMahon RP, Moolchan ET, Feldman S, Richardson CM, Wehring HJ, Heishman SJ (2012) Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia. Schizophr Bull 38(3):543\u2013551","journal-title":"Schizophr Bull"},{"issue":"6","key":"3239_CR28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neubiorev.2005.02.006","volume":"29","author":"V Kumari","year":"2005","unstructured":"Kumari V, Postma P (2005) Nicotine use in schizophrenia: the self-medication hypotheses. Neurosci Biobehav Rev 29(6):1021\u20131034","journal-title":"Neurosci Biobehav Rev"},{"issue":"20","key":"3239_CR29","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1001\/jama.284.20.2606","volume":"284","author":"K Lasser","year":"2000","unstructured":"Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH (2000) Smoking and mental illness: a population-based prevalence study. JAMA 284(20):2606\u20132610","journal-title":"JAMA"},{"issue":"3\u20134","key":"3239_CR30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1300\/J374v03n03_05","volume":"3","author":"S Leonard","year":"2007","unstructured":"Leonard S, Mexal S, Freedman R (2007) Smoking, genetics and schizophrenia: evidence for self medication. J Dual Diagn 3(3\u20134):43\u201359","journal-title":"J Dual Diagn"},{"issue":"2","key":"3239_CR31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ntr\/ntp011","volume":"11","author":"DE Levy","year":"2009","unstructured":"Levy DE, Biener L, Rigotti NA (2009) The natural history of light smokers: a population-based cohort study. Nicotine TobRes 11(2):156\u2013163","journal-title":"Nicotine TobRes"},{"issue":"6","key":"3239_CR32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archpsyc.58.6.573","volume":"58","author":"D Lichtermann","year":"2001","unstructured":"Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, L\u00f6nnqvist J (2001) Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry 58(6):573\u2013578","journal-title":"Arch Gen Psychiatry"},{"issue":"2\u20133","key":"3239_CR33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0920-9964(02)00508-X","volume":"60","author":"A Llerena","year":"2003","unstructured":"Llerena A, de la Rubia A, Penas-Lledo E, Diaz FJ, de Leon J (2003) Schizophrenia and tobacco smoking in a Spanish psychiatric hospital. Schizophr Res 60(2\u20133):313\u2013317","journal-title":"Schizophr Res"},{"issue":"10","key":"3239_CR34","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1176\/ps.50.10.1346","volume":"50","author":"ER Lyon","year":"1999","unstructured":"Lyon ER (1999) A review of the effects of nicotine on schizophrenia and antipsychotic medications. Psychiatr Serv 50(10):1346\u20131350","journal-title":"Psychiatr Serv"},{"key":"3239_CR35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1192\/bjp.183.1.34","volume":"183","author":"RG McCreadie","year":"2003","unstructured":"McCreadie RG, Scottish Schizophrenia Lifestyle Group (2003) Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 183:34\u2013539","journal-title":"Br J Psychiatry"},{"issue":"1","key":"3239_CR36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF02246063","volume":"119","author":"JP McEvoy","year":"1995","unstructured":"McEvoy JP, Freudenreich O, Levin ED, Rose JE (1995) Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology 119(1):124\u2013126","journal-title":"Psychopharmacology"},{"issue":"5","key":"3239_CR37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1521-0391.2011.00150.x","volume":"20","author":"ZS Meszaros","year":"2011","unstructured":"Meszaros ZS, Dimmock JA, Ploutz-Snyder RJ, Abdul-Malak Y, Leontieva L, Canfield K, Batki SL (2011) Predictors of smoking severity in patients with schizophrenia and alcohol use disorders. Am J Addict 20(5):462\u2013467","journal-title":"Am J Addict"},{"key":"3239_CR38","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1055\/s-2008-1081463","volume":"1","author":"A Mobascher","year":"2008","unstructured":"Mobascher A, Winterer G (2008) The molecular and cellular neurobiology of nicotine abuse in schizophrenia. Pharmacopsychiatry 1:S51\u2013S59","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"3239_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3223(96)00302-2","volume":"42","author":"A Olincy","year":"1997","unstructured":"Olincy A, Young DA, Freedman R (1997) Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiatry 42(1):1\u20135","journal-title":"Biol Psychiatry"},{"issue":"5","key":"3239_CR40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00004850-200109000-00007","volume":"16","author":"RM Procyshyn","year":"2001","unstructured":"Procyshyn RM, Ihsan N, Thompson D (2001) A comparison of smoking behaviors between patients treated with clozapine and depot neuroleptics. Int Clin Psychopharmacol 16(5):291\u2013294","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"3239_CR41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archpsyc.62.6.649","volume":"62","author":"KA Sacco","year":"2005","unstructured":"Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP (2005) Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62(6):649\u2013659","journal-title":"Arch Gen Psychiatry"},{"issue":"1\u20133","key":"3239_CR42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.schres.2006.03.025","volume":"85","author":"KA Sacco","year":"2006","unstructured":"Sacco KA, Termine A, Dudas MM, Seyal AA, Allen TM, Vessicchio JC, Wexler BE, George TP (2006) Neuropsychological deficits in nonsmokers with schizophrenia: effects of a nicotinic antagonist. Schizophr Res 85(1\u20133):213\u2013221","journal-title":"Schizophr Res"},{"issue":"3","key":"3239_CR43","first-page":"371","volume":"21","author":"M Sagud","year":"2009","unstructured":"Sagud M, Mihaljevi\u0107-Peles A, M\u00fcck-Seler D, Pivac N, Vuksan-Cusa B, Brataljenovi\u0107 T, Jakovljevi\u0107 M (2009) Smoking and schizophrenia. Psychiatr Danub 21(3):371\u2013375","journal-title":"Psychiatr Danub"},{"issue":"10","key":"3239_CR44","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","volume":"64","author":"S Saha","year":"2007","unstructured":"Saha S, Chant D, McGrath J (2007) A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 64(10):1123\u20131131","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"3239_CR45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0920-9964(96)00083-7","volume":"23","author":"RK Salokangas","year":"1997","unstructured":"Salokangas RK, Saarijarvi S, Taiminen T, Lehto H, Niemi H, Ahola V, Syv\u00e4lahti E (1997) Effect of smoking on neuroleptics in schizophrenia. Schizophr Res 23(1):55\u201360","journal-title":"Schizophr Res"},{"key":"3239_CR46","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1176\/appi.ajp.157.4.632","volume":"157","author":"RK Salokangas","year":"2000","unstructured":"Salokangas RK, Vilkman H, Ilonen T, Taiminen T, Bergman J, Haaparanta M, Solin O, Alanen A, Syv\u00e4lahti E, Hietala J (2000) High levels of dopamine activity in the basal ganglia of cigarette smokers. Am J Psychiatry 157:632\u2013634","journal-title":"Am J Psychiatry"},{"issue":"4","key":"3239_CR47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.eurpsy.2005.07.008","volume":"21","author":"RK Salokangas","year":"2006","unstructured":"Salokangas RK, Honkonen T, Steng\u00e5rd E, Koivisto AM, Hietala J (2006) Cigarette smoking in long-term schizophrenia. Eur Psychiatry 21(4):219\u2013223","journal-title":"Eur Psychiatry"},{"issue":"2","key":"3239_CR48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amepre.2009.03.020","volume":"37","author":"RE Schane","year":"2009","unstructured":"Schane RE, Glantz SA, Ling PM (2009) Social smoking implications for public health, clinical practice, and intervention research. Am J Prev Med 37(2):124\u2013131","journal-title":"Am J Prev Med"},{"key":"3239_CR49","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.npp.1301238","volume":"32","author":"DJ Scott","year":"2007","unstructured":"Scott DJ, Domino EF, Heitzeg MM, Koeppe RA, Ni L, Guthrie S, Zubieta JK (2007) Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans. Neuropsychopharmacology 32:450\u2013457","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"3239_CR50","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1161\/STROKEAHA.107.512632","volume":"39","author":"YM Song","year":"2008","unstructured":"Song YM, Cho HJ (2008) Risk of stroke and myocardial infarction after reduction or cessation of cigarette smoking: a cohort study in Korean men. Stroke 39(9):2432\u20132438","journal-title":"Stroke"},{"issue":"1","key":"3239_CR51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eurpsy.2004.09.005","volume":"20","author":"JE Strand","year":"2005","unstructured":"Strand JE, Nyb\u00e4ck H (2005) Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls. Eur Psychiatry 20(1):50\u201354","journal-title":"Eur Psychiatry"},{"key":"3239_CR52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1744-859X-6-13","volume":"6","author":"JC Sumi\u0107","year":"2007","unstructured":"Sumi\u0107 JC, Bari\u0107 V, Bili\u0107 P, Herceg M, Sisek-Sprem M, Juki\u0107 V (2007) QTc and psychopharmacs: are there any differences between monotherapy and polytherapy. Ann Gen Psychiatry 6:13","journal-title":"Ann Gen Psychiatry"},{"issue":"2","key":"3239_CR53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0306-4603(97)00028-2","volume":"23","author":"TJ Taiminen","year":"1998","unstructured":"Taiminen TJ, Salokangas RK, Saarij\u00e4rvi S, Niemi H, Lehto H, Ahola V, Syv\u00e4lahti E (1998) Smoking and cognitive deficits in schizophrenia: a pilot study. Addict Behav 23(2):263\u2013266","journal-title":"Addict Behav"},{"issue":"1\u20133","key":"3239_CR54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.schres.2007.05.025","volume":"97","author":"YL Tang","year":"2007","unstructured":"Tang YL, Gillespie CF, Epstein MP, Mao PX, Jiang F, Chen Q, Cai ZJ, Mitchell PB (2007) Gender differences in 542 Chinese inpatients with schizophrenia. Schizophr Res 97(1\u20133):88\u201396","journal-title":"Schizophr Res"},{"issue":"2","key":"3239_CR55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.drugalcdep.2005.04.002","volume":"80","author":"JW Tidey","year":"2005","unstructured":"Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM (2005) Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug Alcohol Depend 80(2):259\u2013265","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"3239_CR56","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1037\/0893-164X.17.4.259","volume":"17","author":"PA Vanable","year":"2003","unstructured":"Vanable PA, Carey MP, Carey KB, Maisto SA (2003) Smoking among psychiatric outpatients: relationship to substance use, diagnosis, and illness severity. Psychol Addict Behav 17(4):259\u2013265","journal-title":"Psychol Addict Behav"},{"issue":"2\u20133","key":"3239_CR57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.schres.2012.03.024","volume":"138","author":"HJ Wehring","year":"2012","unstructured":"Wehring HJ, Liu F, McMahon RP, Mackowick KM, Love RC, Dixon L, Kelly DL (2012) Clinical characteristics of heavy and non-heavy smokers with schizophrenia. Schizophr Res 138(2\u20133):285\u2013289","journal-title":"Schizophr Res"},{"issue":"6","key":"3239_CR58","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.addbeh.2004.03.009","volume":"29","author":"JM Williams","year":"2004","unstructured":"Williams JM, Ziedonis D (2004) Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav 29(6):1067\u20131083","journal-title":"Addict Behav"},{"issue":"2\u20133","key":"3239_CR59","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.schres.2005.04.016","volume":"79","author":"JM Williams","year":"2005","unstructured":"Williams JM, Ziedonis DM, Abanyie F, Steinberg ML, Foulds J, Benowitz NL (2005) Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res 79(2\u20133):323\u2013335","journal-title":"Schizophr Res"},{"issue":"8","key":"3239_CR60","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/ntr\/ntq102","volume":"12","author":"JM Williams","year":"2010","unstructured":"Williams JM, Gandhi KK, Lu SE, Kumar S, Shen J, Foulds J, Kipen H, Benowitz NL (2010) Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette. Nicotine Tob Res 12(8):855\u2013859","journal-title":"Nicotine Tob Res"},{"issue":"10","key":"3239_CR61","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2217\/pgs.10.144","volume":"11","author":"G Winterer","year":"2010","unstructured":"Winterer G (2010) Risk gene variants for nicotine dependence: a success story in neuropsychiatric genetics with possible applications to drug development. Pharmacogenomics 11(10):1353\u20131357","journal-title":"Pharmacogenomics"},{"issue":"6","key":"3239_CR62","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","volume":"64","author":"SW Woods","year":"2003","unstructured":"Woods SW (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64(6):663\u2013667","journal-title":"J Clin Psychiatry"},{"key":"3239_CR63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-011-2188-5","volume":"216","author":"FD Yang","year":"2011","unstructured":"Yang FD, Wang XQ, Liu XP, Zhao KX, Fu WH, Hao XR, Zhang XL, Huang GS, Qu SC, Bai JS, Huang XF, Kosten TR, Zhang XY (2011) Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics. Psychopharmacology 216:9\u201316","journal-title":"Psychopharmacology"},{"issue":"11","key":"3239_CR64","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2146\/ajhp070279","volume":"65","author":"WR Zemrak","year":"2008","unstructured":"Zemrak WR, Kenna GA (2008) Association of antipsychotic and antidepressant drugs with Q\u2013T interval prolongation. Am J Health Syst Pharm 65(11):1029\u20131038","journal-title":"Am J Health Syst Pharm"},{"issue":"14","key":"3239_CR65","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jpsychires.2010.02.015","volume":"44","author":"XY Zhang","year":"2010","unstructured":"Zhang XY, Zhang RL, Pan M, Chen DC, Xiu MH, Kosten TR (2010) Sex difference in the prevalence of smoking in Chinese schizophrenia. J Psychiatr Res 44(14):986\u2013988","journal-title":"J Psychiatr Res"},{"issue":"2","key":"3239_CR66","doi-asserted-by":"crossref","first-page":"e30937","DOI":"10.1371\/journal.pone.0030937","volume":"7","author":"XY Zhang","year":"2012","unstructured":"Zhang XY, Liang J, da Chen C, Xiu MH, He J, Cheng W, Wu Z, Yang FD, Haile CN, Sun H, Lu L, Kosten TA, Kosten TR (2012) Cigarette smoking in male patients with chronic schizophrenia in a Chinese population: prevalence and relationship to clinical phenotypes. PLoS One 7(2):e30937","journal-title":"PLoS One"},{"issue":"3","key":"3239_CR67","first-page":"204","volume":"45","author":"DM Ziedonis","year":"1994","unstructured":"Ziedonis DM, Kosten TR, Glazer WM, Frances RJ (1994) Nicotine dependence and schizophrenia. Hosp Community Psychiatry 45(3):204\u2013206","journal-title":"Hosp. Community Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-013-3239-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3239-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T23:27:54Z","timestamp":1688426874000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-013-3239-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,21]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["3239"],"URL":"https:\/\/doi.org\/10.1007\/s00213-013-3239-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,21]]}}}